Navamedic ASA

Nordic pharma company founded in 2002 and listed on the Oslo Stock Exchange (NAVA) since 2006. Supplies Rx, OTC, medical nutrition, supplements and cosmetics across all Nordic countries, Baltics and Benelux. Portfolio includes Mysimba (obesity), Ventizolve® (intranasal naloxone for opioid overdose), Levopidon® and methadone (opioid substitution therapy) and medical nutrition for rare diseases.